Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A novel class of ZNF384 aberrations in acute leukemia

M. Zaliova, L. Winkowska, J. Stuchly, K. Fiser, P. Triska, M. Zwyrtkova, O. Hrusak, J. Starkova, L. Sramkova, J. Stary, J. Trka, J. Zuna

. 2021 ; 5 (21) : 4393-4397. [pub] 20211109

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Fusion of the ZNF384 gene as the 3' partner to several different 5' partner genes occurs recurrently in B-cell precursor acute lymphoblastic and mixed phenotype B/myeloid leukemia. These canonical fusions (ZNF384r) contain the complete ZNF384 coding sequence and are associated with a specific gene expression signature. Cases with this signature, but without canonical ZNF384 fusions (ZNF384r-like cases), have been described previously. Although some have been shown to harbor ZNF362 fusions, the primary aberrations remain unknown in a major proportion. We studied 3 patients with the ZNF384r signature and unknown primary genetic background and identified a previously unknown class of genetic aberration affecting the last exon of ZNF384 and resulting in disruption of the C-terminal portion of the ZNF384 protein. Importantly, in 2 cases, the ZNF384 aberration, indel, was missed during the bioinformatic analysis but revealed by the manual, targeted reanalysis. Two cases with the novel aberrations had a mixed (B/myeloid) immunophenotype commonly associated with canonical ZNF384 fusions. In conclusion, we present leukemia cases with a novel class of ZNF384 aberrations that phenocopy leukemia with ZNF384r. Therefore, we show that part of the so-called ZNF384r-like cases represent the same genetic subtype as leukemia with canonical ZNF384 fusions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003219
003      
CZ-PrNML
005      
20220127150550.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1182/bloodadvances.2021005318 $2 doi
035    __
$a (PubMed)34529760
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zaliova, Marketa $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u University Hospital Motol, Prague, Czech Republic
245    12
$a A novel class of ZNF384 aberrations in acute leukemia / $c M. Zaliova, L. Winkowska, J. Stuchly, K. Fiser, P. Triska, M. Zwyrtkova, O. Hrusak, J. Starkova, L. Sramkova, J. Stary, J. Trka, J. Zuna
520    9_
$a Fusion of the ZNF384 gene as the 3' partner to several different 5' partner genes occurs recurrently in B-cell precursor acute lymphoblastic and mixed phenotype B/myeloid leukemia. These canonical fusions (ZNF384r) contain the complete ZNF384 coding sequence and are associated with a specific gene expression signature. Cases with this signature, but without canonical ZNF384 fusions (ZNF384r-like cases), have been described previously. Although some have been shown to harbor ZNF362 fusions, the primary aberrations remain unknown in a major proportion. We studied 3 patients with the ZNF384r signature and unknown primary genetic background and identified a previously unknown class of genetic aberration affecting the last exon of ZNF384 and resulting in disruption of the C-terminal portion of the ZNF384 protein. Importantly, in 2 cases, the ZNF384 aberration, indel, was missed during the bioinformatic analysis but revealed by the manual, targeted reanalysis. Two cases with the novel aberrations had a mixed (B/myeloid) immunophenotype commonly associated with canonical ZNF384 fusions. In conclusion, we present leukemia cases with a novel class of ZNF384 aberrations that phenocopy leukemia with ZNF384r. Therefore, we show that part of the so-called ZNF384r-like cases represent the same genetic subtype as leukemia with canonical ZNF384 fusions.
650    _2
$a lidé $7 D006801
650    _2
$a imunofenotypizace $7 D016130
650    12
$a akutní myeloidní leukemie $x genetika $7 D015470
650    12
$a trans-aktivátory $x genetika $7 D015534
650    _2
$a transkripční faktory $7 D014157
650    _2
$a transkriptom $7 D059467
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Winkowska, Lucie $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; and
700    1_
$a Stuchly, Jan $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; and
700    1_
$a Fiser, Karel $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; and
700    1_
$a Triska, Petr $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; and
700    1_
$a Zwyrtkova, Martina $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; and
700    1_
$a Hrusak, Ondrej $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u University Hospital Motol, Prague, Czech Republic
700    1_
$a Starkova, Julia $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u University Hospital Motol, Prague, Czech Republic
700    1_
$a Sramkova, Lucie $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; and $u University Hospital Motol, Prague, Czech Republic
700    1_
$a Stary, Jan $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; and $u University Hospital Motol, Prague, Czech Republic
700    1_
$a Trka, Jan $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u University Hospital Motol, Prague, Czech Republic
700    1_
$a Zuna, Jan $u Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u University Hospital Motol, Prague, Czech Republic
773    0_
$w MED00194912 $t Blood advances $x 2473-9537 $g Roč. 5, č. 21 (2021), s. 4393-4397
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34529760 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150546 $b ABA008
999    __
$a ok $b bmc $g 1750852 $s 1154368
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 5 $c 21 $d 4393-4397 $e 20211109 $i 2473-9537 $m Blood advances $n Blood Adv $x MED00194912
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...